We must also point it that a surprising proportion of IDH mutant gliomas are unmethylated—this may reflect the relative insensitivity of MS-PCR (methylation-specific polymerase chain reaction) compared to other methods, for example DNA pyrosequencing, for MGMT promoter methylation [20]. The gene discussed is IDH1; the disease is central nervous system cancer.